A novel siRNA validation system for functional screening and identification of effective RNAi probes in mammalian cells

Biochemical and Biophysical Research Communications

Volumn 346, Issue 3, 2006, Pages 707-720

  Hung, Chuan Fu ^a   Lu, Kuang Chu ^a   Cheng, Tsung Lin ^a   Wu, Ren Huang ^a   Huang, Lin Ya ^a   Teng, Chiao Fang ^a   Chang, Wen Tsan ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

AKT1; EGFP; Firefly luciferase; HBsAg; LMP1; MMP 7; p53; pDual; RNAi; siRNA

Indexed keywords

DNA FRAGMENT; ENHANCED GREEN FLUORESCENT PROTEIN; FIREFLY LUCIFERASE; GLUTATHIONE TRANSFERASE; HEPATITIS B SURFACE ANTIBODY; LATENT MEMBRANE PROTEIN 1; MATRILYSIN; PLASMID VECTOR; PROTEIN KINASE B; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SYNTHETIC DNA; VIRUS VECTOR;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG SCREENING; DRUG TARGETING; EMBRYO; EXPRESSION VECTOR; FEMALE; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INSERTION; GENE PROBE; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MAMMAL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARAMETERS OF MEASUREMENT AND ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RELIABILITY; REPORTER GENE; RNA ANALYSIS; RNA INTERFERENCE; RNA SEQUENCE; VALIDATION PROCESS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL LINE; CELLS; CRICETINAE; GENES, REPORTER; GENETIC VECTORS; HUMANS; MICE; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

HEPATITIS B VIRUS; HUMAN HERPESVIRUS 4; MAMMALIA;

EID: 33745200043     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.164     Document Type: Article

References (57)

1. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998) 806-811
2. Dykxhoorn D.M., Novina C.D., and Sharp P.A. Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol. 4 (2003) 457-467
3. Schramke V., and Allshire R. Hairpin RNAs and retrotransposon LTRs effect RNAi and chromatin-based gene silencing. Science 301 (2003) 1069-1074
4. Soifer H.S., Zaragoza A., Peyvan M., Behlke M.A., and Rossi J.J. A potential role for RNA interference in controlling the activity of the human LINE-1 retrotransposon. Nucleic Acids Res. 33 (2005) 846-856
5. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., and Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 (2000) 901-906
6. Volpe T.A., Kidner C., Hall I.M., Teng G., Grewal S.I., and Martienssen R.A. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science 297 (2002) 1833-1837
7. Matzke M.A., and Birchler J.A. RNAi-mediated pathways in the nucleus. Nat. Rev. Genet. 6 (2005) 24-35
8. Tuschl T. Functional genomics: RNA sets the standard. Nature 421 (2003) 220-221
9. Berns K., Hijmans E.M., Mullenders J., Brummelkamp T.R., Velds A., Heimerikx M., Kerkhoven R.M., Madiredjo M., Nijkamp W., Weigelt B., et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428 (2004) 431-437
10. Paddison P.J., Silva J.M., Conklin D.S., Schlabach M., Li M., Aruleba S., Balija V., O'Shaughnessy A., Gnoj L., Scobie K., et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 428 (2004) 427-431
11. Silva J., Chang K., Hannon G.J., and Rivas F.V. RNA-interference-based functional genomics in mammalian cells: reverse genetics coming of age. Oncogene 23 (2004) 8401-8409
12. Shuey D.J., McCallus D.E., and Giordano T. RNAi: gene-silencing in therapeutic intervention. Drug Discov. Today 7 (2002) 1040-1046
13. Hannon G.J., and Rossi J.J. Unlocking the potential of the human genome with RNA interference. Nature 431 (2004) 371-378
14. Scherer L.J., and Rossi J.J. Approaches for the sequence-specific knockdown of mRNA. Nat. Biotechnol. 21 (2003) 1457-1465
15. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (2001) 494-498
16. Dorsett Y., and Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov. 3 (2004) 318-329
17. Siolas D., Lerner C., Burchard J., Ge W., Linsley P.S., Paddison P.J., Hannon G.J., and Cleary M.A. Synthetic shRNA as potent RNAi triggers. Nat. Biotechnol. 23 (2005) 227-231
18. Brummelkamp T.R., Bernards R., and Agami R.A. system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
19. Sui G., Soohoo C., Affar E.B., Gay F., Shi Y., Forrester W.C., and Shi Y. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99 (2002) 5515-5520
20. Paddison P.J., Caudy A.A., Bernstein E., Hannon G.J., and Conklin D.S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16 (2002) 948-958
21. Paul C.P., Good P.D., Winer I., and Engelke D.R. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20 (2002) 505-508
22. Lee N.S., Dohjima T., Bauer G., Li H., Li M.J., Ehsani A., Salvaterra P., and Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20 (2002) 500-505
23. Miyagishi M., and Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 20 (2002) 497-500
24. Zheng L., Liu J., Batalov S., Zhou D., Orth A., Ding S., and Schultz P.G. An approach to genomewide screens of expressed small interfering RNAs in mammalian cells. Proc. Natl. Acad. Sci. USA 101 (2004) 135-140
25. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., and Khvorova A. Rational siRNA design for RNA interference. Nat. Biotechnol. 22 (2004) 326-330
26. Holen T., Amarzguioui M., Wiiger M.T., Babaie E., and Prydz H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 30 (2002) 1757-1766
27. Harborth J., Elbashir S.M., Vandenburgh K., Manninga H., Scaringe S.A., Weber K., and Tuschl T. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev. 13 (2003) 83-105
28. Kretschmer-Kazemi Far R., and Sczakiel G. The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides. Nucleic Acids Res. 31 (2003) 4417-4424
29. Heale B.S.E., Soifer H.S., Bowers C., and Rossi J.J. siRNA target site secondary structure predictions using local stable substructures. Nucleic Acids Res. 33 (2005) e30
30. Khvorova A., Reynolds A., and Jayasena S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 115 (2003) 209-216
31. Schwarz D.S., Hutvagner G., Du T., Xu Z., Aronin N., and Zamore P.D. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115 (2003) 199-208
32. Mittal V. Improving the efficiency of RNA interference in mammals. Nat. Rev. Genet. 5 (2004) 355-365
33. Ui-Tei K., Naito Y., Takahashi F., Haraguchi T., Ohki-Hamazaki H., Juni A., Ueda R., and Saigo K. Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res. 32 (2004) 936-948
34. Kumar R., Conklin D.S., and Mittal V. High-throughput selection of effective RNAi probes for gene silencing. Genome Res. 13 (2003) 2333-2340
35. Du Q., Thonberg H., Zhang H.Y., Wahlestedt C., and Liang Z. Validating siRNA using a reporter made from synthetic DNA oligonucleotides. Biochem. Biophys. Res. Commun. 325 (2004) 243-249
36. Smart N., Scambler P.J., and Riley P.R. A rapid and sensitive assay for quantification of siRNA efficiency and specificity. Biol. Proced. Online 7 (2005) 1-7
37. Cheng T.-L., Chang W.-W., Su I.-J., Lai M.-D., Huang W., Lei H.-Y., and Chang W.-T. Therapeutic inhibition of hepatitis B virus surface antigen expression by RNA interference. Biochem. Biophys. Res. Commun. 336 (2005) 820-830
38. Wu M.-T., Wu R.-H., Hung C.-F., Cheng T.-L., Tsai W.-H., and Chang W.-T. Simple and efficient DNA vector-based RNAi systems in mammalian cells. Biochem. Biophys. Res. Commun. 330 (2005) 53-59
39. Gupta S., Schoer R.A., Egan J.E., Hannon G.J., and Mittal V. Inducible, reversible, and stable RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 101 (2004) 1927-1932
40. Wielockx B., Libert C., and Wilson C. Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?. Cytokine Growth Factor Rev. 15 (2004) 111-115
41. Young L.S., and Rickinson A.B. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4 (2004) 757-768
42. Kenney J.L., Guinness M.E., Curiel T., and Lacy J. Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells. Blood 92 (1998) 1721-1727
43. Kennedy G., Komano J., and Sugden B. Epstein-Barr virus provides a survival factor to Burkitt's lymphomas. Proc. Natl. Acad. Sci. USA 100 (2003) 14269-14274
44. Vivanco I., and Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2 (2002) 489-501
45. Hennessy B.T., Smith D.L., Ram P.T., Lu Y., and Mills G.B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 4 (2005) 988-1004
46. Tiscornia G., Singer O., Ikawa M., and Verma I.M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. USA 100 (2003) 1844-1848
47. Joost Haasnoot P.C., Cupac D., and Berkhout B. Inhibition of virus replication by RNA interference. J. Biomed. Sci. 10 (2003) 607-616
48. Saksela K. Human viruses under attack by small inhibitory RNA. Trends Microbiol. 11 (2003) 345-347
49. Gitlin L., Karelsky S., and Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418 (2002) 430-434
50. Jacque J.M., Triques K., and Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 418 (2002) 435-438
51. Kapadia S.B., Brideau-Andersen A., and Chisari F.V. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl. Acad. Sci. USA 100 (2003) 2014-2018
52. Ge Q., McManus M.T., Nguyen T., Shen C.H., Sharp P.A., Eisen H.N., and Chen J. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc. Natl. Acad. Sci. USA 100 (2003) 2718-2723
53. Caplen N.J., Zheng Z., Falgout B., and Morgan R.A. Inhibition of viral gene expression and replication in mosquito cells by dsRNA-triggered RNA interference. Mol. Ther. 6 (2002) 243-251
54. McCaffrey A.P., Nakai H., Pandey K., Huang Z., Salazar F.H., Xu H., Wieland S.F., Marion P.L., and Kay M.A. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21 (2003) 639-644
55. Shlomai A., and Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 37 (2003) 764-770
56. Kuiken T., Fouchier R., Rimmelzwaan G., and Osterhaus A. Emerging viral infections in a rapidly changing world. Curr. Opin. Biotechnol. 14 (2003) 641-646
57. Morens D.M., Folkers G.K., and Fauci A.S. The challenge of emerging and re-emerging infectious diseases. Nature 430 (2004) 242-249